Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease : revisiting hepatic lipid peroxidation
Source
EBioMedicine - ISSN 2352-3964-102 (2024) p. 1-18
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD)
Source
Frontiers in molecular medicine - ISSN 2674-0095-3 (2024) p. 1-19
The role of adipose tissue and subsequent liver tissue hypoxia in obesity and early stage metabolic dysfunction associated steatotic liver disease
Source
International journal of obesity - ISSN 0307-0565-48:4 (2024) p. 512-522
Ferroptosis and pyroptosis signatures in critical COVID-19 patients
Source
Cell death and differentiation - ISSN 1350-9047-30:9 (2023) p. 2066-2077
Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes
Source
JHEP Reports - ISSN 2589-5559-5:7 (2023) p. 1-12